Stock Events

Stock Events

Nuwellis 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q4 2025
Next
-1.34
-1.18
-1.02
-0.85
Expected EPS
-0.8528
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 22S0.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap8.61B
Baxter International Inc. offers renal and hospital products competing in fluid management and treatment, similar to Nuwellis' therapeutic fluid management technologies.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc provides medical technologies, services, and solutions, including those for heart failure and fluid management, directly competing with Nuwellis' offerings.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing in areas like fluid management.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, offering products that compete in the cardiovascular and critical care space with Nuwellis.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories operates in various segments, including heart failure and vascular devices, which can be seen as competitive to Nuwellis' fluid management solutions.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those that could be used in fluid management and cardiovascular care.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation's life sciences and diagnostics segments offer products that compete in the medical device and diagnostics field, relevant to Nuwellis' market.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc., while primarily focused on musculoskeletal healthcare, has products and solutions that can indirectly compete with Nuwellis in the healthcare market.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation specializes in medical and surgical equipment and neurotechnology, competing in the broader medical device market against Nuwellis.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products, competing in the healthcare market where Nuwellis also operates.

About

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Show more...
CEO
Mr. John L. Erb
Employees
38
Country
United States
ISIN
US67113Y7022

Listings

F
DE
22S0.F
STU
DE
22S0.STU
XNAS
US
NUWE
BOATS
BOATS
NUWE.BOATS

0 Comments

Share your thoughts

FAQ

What is Nuwellis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuwellis stocks are traded under the ticker 22S0.STU.
When is the next Nuwellis earnings date?▼
Nuwellis is going to release the next earnings report on May 12, 2026.
What were Nuwellis earnings last quarter?▼
22S0.STU earnings for the last quarter are -1.29 EUR per share, whereas the estimation was -1.34 EUR resulting in a +3.85% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Nuwellis have?▼
As of April 12, 2026, the company has 38 employees.
In which sector is Nuwellis located?▼
Nuwellis operates in the Health & Wellness sector.
When did Nuwellis complete a stock split?▼
Nuwellis has not had any recent stock splits.
Where is Nuwellis headquartered?▼
Nuwellis is headquartered in Eden Prairie, United States.